- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-8190
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Chimeric antigen receptor T cell therapy for multiple myeloma ; volume:39 ; number:1 ; day:4 ; month:6 ; year:2019 ; pages:1-5 ; date:12.2019
Inflammation and regeneration ; 39, Heft 1 (4.6.2019), 1-5, 12.2019
- Urheber
-
Hasegawa, Kana
Hosen, Naoki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41232-019-0100-6
- URN
-
urn:nbn:de:101:1-2019112819121207347640
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hasegawa, Kana
- Hosen, Naoki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy